Positive tendency and problems of outpatient treatment of chronic bronchitis exacerbation: results of a pharmacoeconomic trial
Abstract
A comparative analysis of medication in chronic bronchitis exacerbation was performed based on medical histories during 1998 to 2001. Positive shifts were found regarding to rarer administration of obsolete antimicrobials with insufficient activity against common pathogens and high toxity and to rarer application of drugs with not proven clinical efficacy in this disease. Current problems were quite total antibacterial therapy, choice of antibiotics not considering sensitivity of the pathogen, underestimation of a role of bronchodilating therapy.
References
1. Reynolds H.Y. Chronic bronchitis and acute infectious exacerbations. In: Mandell G.L., Bennett J.E., Dolin R. eds. Principles and practice of infectious diseases. 5-th ed. Philadelphia: Churchill Livingstone; 2000. 706-710.
2. Ball P., Make B. Acute exacerbations of chronic bronchitis. An international comparison. Chest 1998; 113: 199-204.
3. Chodosh S. Role of antimicrobials in the management of acute exacerbations of chronic bronchitis. Infect. Med. 1999; 16: 8-20.
4. Хронические обструктивные болезни легких. Федеральная программа. М.; 1999. 6-7, 26-35.
5. Madison J.M. Chronic obstructive pulmonary disease. Lancet 1998; 352: 467-473.
6. Авдеев C.H., Чучалин А.Г. Роль бактериальной инфекции и выбор антибиотиков при обострении хронического бронхита. Consilium Medicum 2000; 2: 418-426.
7. Anzueto A., Niederman M.S., Tillotson G.S. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Clin. Ther. 1998; 20: 885-900.
8. Anthonisen N.R., Manfreda J., Warren C.P.W. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204.
9. Saint S., Bent S.t Vittinghoff E., Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a metaanalysis. J.A.M.A. 1995; 273: 957-960.
10. Grossman R. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest 1997; 112 (suppl.): 310S-313S.
11. Страчунский Л.С., Богданович Т.М. Состояние резистентности к антиинфекционным препаратам в России. В кн.: Страчунский Л.С., Белоусов Ю.Б., Козлов С.Н. (ред.). Практическое руководство по антиинфекционной химиотерапии. М.: Боргес; 2002. 32-39.
12. Mandell G.L., Perti W.A. Jr. Penicillins, Cephalosporins, and other (3-lactam antibiotics. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W. eds. The pharmacological basis of therapeutics. 9-th ed. New York: McGraw-Hill; 1996. 1073-1102.
13. Gilbert D.N. Aminoglycosides. In: Mandell G.L., Bennett J.E., Dolin R. eds. Principles and practice of infectious diseases. 5-th ed. Philadelphia: Churchill Livingstone; 2000. 307-336.
14. Serafin W.E. Drugs used in the treatment of asthma. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., eds. The pharmacological basis of therapeutics. 9-th ed. New York: McGraw-Hill; 1996. 659-682.
Review
For citations:
Kozlov S.N. Positive tendency and problems of outpatient treatment of chronic bronchitis exacerbation: results of a pharmacoeconomic trial. PULMONOLOGIYA. 2004;(3):60-64. (In Russ.)
Views:
153
Email this article 